Global Equine Rabies Immunoglobulin (Erig) Market Research Report 2025(Status and Outlook)
Report Overview
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The global Equine Rabies Immunoglobulin (Erig) market size was estimated at USD 75.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Equine Rabies Immunoglobulin (Erig) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Equine Rabies Immunoglobulin (Erig) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Equine Rabies Immunoglobulin (Erig) market
Global Equine Rabies Immunoglobulin (Erig) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Market Segmentation (by Type)
1500IU
1000IU
400IU
Other
Market Segmentation (by Application)
Category II Exposure
Category III Exposure
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Rabies Immunoglobulin (Erig) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Equine Rabies Immunoglobulin (Erig), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The global Equine Rabies Immunoglobulin (Erig) market size was estimated at USD 75.25 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Equine Rabies Immunoglobulin (Erig) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Equine Rabies Immunoglobulin (Erig) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Equine Rabies Immunoglobulin (Erig) market
Global Equine Rabies Immunoglobulin (Erig) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Market Segmentation (by Type)
1500IU
1000IU
400IU
Other
Market Segmentation (by Application)
Category II Exposure
Category III Exposure
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Equine Rabies Immunoglobulin (Erig) Market
- Overview of the regional outlook of the Equine Rabies Immunoglobulin (Erig) Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Equine Rabies Immunoglobulin (Erig) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Equine Rabies Immunoglobulin (Erig), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Equine Rabies Immunoglobulin (Erig)
1.2 Key Market Segments
1.2.1 Equine Rabies Immunoglobulin (Erig) Segment by Type
1.2.2 Equine Rabies Immunoglobulin (Erig) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Equine Rabies Immunoglobulin (Erig) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Equine Rabies Immunoglobulin (Erig) Product Life Cycle
3.3 Global Equine Rabies Immunoglobulin (Erig) Sales by Manufacturers (2020-2025)
3.4 Global Equine Rabies Immunoglobulin (Erig) Revenue Market Share by Manufacturers (2020-2025)
3.5 Equine Rabies Immunoglobulin (Erig) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Equine Rabies Immunoglobulin (Erig) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Equine Rabies Immunoglobulin (Erig) Market Competitive Situation and Trends
3.8.1 Equine Rabies Immunoglobulin (Erig) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Equine Rabies Immunoglobulin (Erig) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 EQUINE RABIES IMMUNOGLOBULIN (ERIG) INDUSTRY CHAIN ANALYSIS
4.1 Equine Rabies Immunoglobulin (Erig) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Equine Rabies Immunoglobulin (Erig) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Equine Rabies Immunoglobulin (Erig) Market
5.7 ESG Ratings of Leading Companies
6 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Type (2020-2025)
6.3 Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Type (2020-2025)
6.4 Global Equine Rabies Immunoglobulin (Erig) Price by Type (2020-2025)
7 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Rabies Immunoglobulin (Erig) Market Sales by Application (2020-2025)
7.3 Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) by Application (2020-2025)
7.4 Global Equine Rabies Immunoglobulin (Erig) Sales Growth Rate by Application (2020-2025)
8 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET SALES BY REGION
8.1 Global Equine Rabies Immunoglobulin (Erig) Sales by Region
8.1.1 Global Equine Rabies Immunoglobulin (Erig) Sales by Region
8.1.2 Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region
8.2 Global Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.2.1 Global Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.2.2 Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region
8.3 North America
8.3.1 North America Equine Rabies Immunoglobulin (Erig) Sales by Country
8.3.2 North America Equine Rabies Immunoglobulin (Erig) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Equine Rabies Immunoglobulin (Erig) Sales by Country
8.4.2 Europe Equine Rabies Immunoglobulin (Erig) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales by Region
8.5.2 Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Equine Rabies Immunoglobulin (Erig) Sales by Country
8.6.2 South America Equine Rabies Immunoglobulin (Erig) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales by Region
8.7.2 Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET PRODUCTION BY REGION
9.1 Global Production of Equine Rabies Immunoglobulin (Erig) by Region(2020-2025)
9.2 Global Equine Rabies Immunoglobulin (Erig) Revenue Market Share by Region (2020-2025)
9.3 Global Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Equine Rabies Immunoglobulin (Erig) Production
9.4.1 North America Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.4.2 North America Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Equine Rabies Immunoglobulin (Erig) Production
9.5.1 Europe Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.5.2 Europe Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Equine Rabies Immunoglobulin (Erig) Production (2020-2025)
9.6.1 Japan Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.6.2 Japan Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Equine Rabies Immunoglobulin (Erig) Production (2020-2025)
9.7.1 China Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.7.2 China Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Serum China
10.1.1 Serum China Basic Information
10.1.2 Serum China Equine Rabies Immunoglobulin (Erig) Product Overview
10.1.3 Serum China Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.1.4 Serum China Business Overview
10.1.5 Serum China SWOT Analysis
10.1.6 Serum China Recent Developments
10.2 Lanzhou Institute of Biological Products
10.2.1 Lanzhou Institute of Biological Products Basic Information
10.2.2 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
10.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.2.4 Lanzhou Institute of Biological Products Business Overview
10.2.5 Lanzhou Institute of Biological Products SWOT Analysis
10.2.6 Lanzhou Institute of Biological Products Recent Developments
10.3 Wuhan Institute of Biological Products
10.3.1 Wuhan Institute of Biological Products Basic Information
10.3.2 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
10.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.3.4 Wuhan Institute of Biological Products Business Overview
10.3.5 Wuhan Institute of Biological Products SWOT Analysis
10.3.6 Wuhan Institute of Biological Products Recent Developments
10.4 Premium Serums
10.4.1 Premium Serums Basic Information
10.4.2 Premium Serums Equine Rabies Immunoglobulin (Erig) Product Overview
10.4.3 Premium Serums Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.4.4 Premium Serums Business Overview
10.4.5 Premium Serums Recent Developments
10.5 Haffkine Bio-Pharmaceutical
10.5.1 Haffkine Bio-Pharmaceutical Basic Information
10.5.2 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Product Overview
10.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.5.4 Haffkine Bio-Pharmaceutical Business Overview
10.5.5 Haffkine Bio-Pharmaceutical Recent Developments
10.6 Bharat Serums
10.6.1 Bharat Serums Basic Information
10.6.2 Bharat Serums Equine Rabies Immunoglobulin (Erig) Product Overview
10.6.3 Bharat Serums Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.6.4 Bharat Serums Business Overview
10.6.5 Bharat Serums Recent Developments
11 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET FORECAST BY REGION
11.1 Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast
11.2 Global Equine Rabies Immunoglobulin (Erig) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country
11.2.3 Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Region
11.2.4 South America Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Equine Rabies Immunoglobulin (Erig) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Equine Rabies Immunoglobulin (Erig) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (Erig) by Type (2026-2033)
12.1.2 Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Equine Rabies Immunoglobulin (Erig) by Type (2026-2033)
12.2 Global Equine Rabies Immunoglobulin (Erig) Market Forecast by Application (2026-2033)
12.2.1 Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) Forecast by Application
12.2.2 Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Equine Rabies Immunoglobulin (Erig)
1.2 Key Market Segments
1.2.1 Equine Rabies Immunoglobulin (Erig) Segment by Type
1.2.2 Equine Rabies Immunoglobulin (Erig) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Equine Rabies Immunoglobulin (Erig) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Equine Rabies Immunoglobulin (Erig) Product Life Cycle
3.3 Global Equine Rabies Immunoglobulin (Erig) Sales by Manufacturers (2020-2025)
3.4 Global Equine Rabies Immunoglobulin (Erig) Revenue Market Share by Manufacturers (2020-2025)
3.5 Equine Rabies Immunoglobulin (Erig) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Equine Rabies Immunoglobulin (Erig) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Equine Rabies Immunoglobulin (Erig) Market Competitive Situation and Trends
3.8.1 Equine Rabies Immunoglobulin (Erig) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Equine Rabies Immunoglobulin (Erig) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 EQUINE RABIES IMMUNOGLOBULIN (ERIG) INDUSTRY CHAIN ANALYSIS
4.1 Equine Rabies Immunoglobulin (Erig) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Equine Rabies Immunoglobulin (Erig) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Equine Rabies Immunoglobulin (Erig) Market
5.7 ESG Ratings of Leading Companies
6 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Type (2020-2025)
6.3 Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Type (2020-2025)
6.4 Global Equine Rabies Immunoglobulin (Erig) Price by Type (2020-2025)
7 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Equine Rabies Immunoglobulin (Erig) Market Sales by Application (2020-2025)
7.3 Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) by Application (2020-2025)
7.4 Global Equine Rabies Immunoglobulin (Erig) Sales Growth Rate by Application (2020-2025)
8 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET SALES BY REGION
8.1 Global Equine Rabies Immunoglobulin (Erig) Sales by Region
8.1.1 Global Equine Rabies Immunoglobulin (Erig) Sales by Region
8.1.2 Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region
8.2 Global Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.2.1 Global Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.2.2 Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region
8.3 North America
8.3.1 North America Equine Rabies Immunoglobulin (Erig) Sales by Country
8.3.2 North America Equine Rabies Immunoglobulin (Erig) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Equine Rabies Immunoglobulin (Erig) Sales by Country
8.4.2 Europe Equine Rabies Immunoglobulin (Erig) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales by Region
8.5.2 Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Equine Rabies Immunoglobulin (Erig) Sales by Country
8.6.2 South America Equine Rabies Immunoglobulin (Erig) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales by Region
8.7.2 Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET PRODUCTION BY REGION
9.1 Global Production of Equine Rabies Immunoglobulin (Erig) by Region(2020-2025)
9.2 Global Equine Rabies Immunoglobulin (Erig) Revenue Market Share by Region (2020-2025)
9.3 Global Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Equine Rabies Immunoglobulin (Erig) Production
9.4.1 North America Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.4.2 North America Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Equine Rabies Immunoglobulin (Erig) Production
9.5.1 Europe Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.5.2 Europe Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Equine Rabies Immunoglobulin (Erig) Production (2020-2025)
9.6.1 Japan Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.6.2 Japan Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Equine Rabies Immunoglobulin (Erig) Production (2020-2025)
9.7.1 China Equine Rabies Immunoglobulin (Erig) Production Growth Rate (2020-2025)
9.7.2 China Equine Rabies Immunoglobulin (Erig) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Serum China
10.1.1 Serum China Basic Information
10.1.2 Serum China Equine Rabies Immunoglobulin (Erig) Product Overview
10.1.3 Serum China Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.1.4 Serum China Business Overview
10.1.5 Serum China SWOT Analysis
10.1.6 Serum China Recent Developments
10.2 Lanzhou Institute of Biological Products
10.2.1 Lanzhou Institute of Biological Products Basic Information
10.2.2 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
10.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.2.4 Lanzhou Institute of Biological Products Business Overview
10.2.5 Lanzhou Institute of Biological Products SWOT Analysis
10.2.6 Lanzhou Institute of Biological Products Recent Developments
10.3 Wuhan Institute of Biological Products
10.3.1 Wuhan Institute of Biological Products Basic Information
10.3.2 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
10.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.3.4 Wuhan Institute of Biological Products Business Overview
10.3.5 Wuhan Institute of Biological Products SWOT Analysis
10.3.6 Wuhan Institute of Biological Products Recent Developments
10.4 Premium Serums
10.4.1 Premium Serums Basic Information
10.4.2 Premium Serums Equine Rabies Immunoglobulin (Erig) Product Overview
10.4.3 Premium Serums Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.4.4 Premium Serums Business Overview
10.4.5 Premium Serums Recent Developments
10.5 Haffkine Bio-Pharmaceutical
10.5.1 Haffkine Bio-Pharmaceutical Basic Information
10.5.2 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Product Overview
10.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.5.4 Haffkine Bio-Pharmaceutical Business Overview
10.5.5 Haffkine Bio-Pharmaceutical Recent Developments
10.6 Bharat Serums
10.6.1 Bharat Serums Basic Information
10.6.2 Bharat Serums Equine Rabies Immunoglobulin (Erig) Product Overview
10.6.3 Bharat Serums Equine Rabies Immunoglobulin (Erig) Product Market Performance
10.6.4 Bharat Serums Business Overview
10.6.5 Bharat Serums Recent Developments
11 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET FORECAST BY REGION
11.1 Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast
11.2 Global Equine Rabies Immunoglobulin (Erig) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country
11.2.3 Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Region
11.2.4 South America Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Equine Rabies Immunoglobulin (Erig) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Equine Rabies Immunoglobulin (Erig) Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (Erig) by Type (2026-2033)
12.1.2 Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Equine Rabies Immunoglobulin (Erig) by Type (2026-2033)
12.2 Global Equine Rabies Immunoglobulin (Erig) Market Forecast by Application (2026-2033)
12.2.1 Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) Forecast by Application
12.2.2 Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Rabies Immunoglobulin (Erig) Market Size Comparison by Region (M USD)
Table 5. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Equine Rabies Immunoglobulin (Erig) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Equine Rabies Immunoglobulin (Erig) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (Erig) as of 2024)
Table 10. Global Market Equine Rabies Immunoglobulin (Erig) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Equine Rabies Immunoglobulin (Erig) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Equine Rabies Immunoglobulin (Erig) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Equine Rabies Immunoglobulin (Erig) Sales by Type (K MT)
Table 26. Global Equine Rabies Immunoglobulin (Erig) Market Size by Type (M USD)
Table 27. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) by Type (2020-2025)
Table 28. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Type (2020-2025)
Table 29. Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) by Type (2020-2025)
Table 30. Global Equine Rabies Immunoglobulin (Erig) Market Size Share by Type (2020-2025)
Table 31. Global Equine Rabies Immunoglobulin (Erig) Price (USD/KG) by Type (2020-2025)
Table 32. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) by Application
Table 33. Global Equine Rabies Immunoglobulin (Erig) Market Size by Application
Table 34. Global Equine Rabies Immunoglobulin (Erig) Sales by Application (2020-2025) & (K MT)
Table 35. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Application (2020-2025)
Table 36. Global Equine Rabies Immunoglobulin (Erig) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application (2020-2025)
Table 38. Global Equine Rabies Immunoglobulin (Erig) Sales Growth Rate by Application (2020-2025)
Table 39. Global Equine Rabies Immunoglobulin (Erig) Sales by Region (2020-2025) & (K MT)
Table 40. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region (2020-2025)
Table 41. Global Equine Rabies Immunoglobulin (Erig) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region (2020-2025)
Table 43. North America Equine Rabies Immunoglobulin (Erig) Sales by Country (2020-2025) & (K MT)
Table 44. North America Equine Rabies Immunoglobulin (Erig) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Equine Rabies Immunoglobulin (Erig) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Equine Rabies Immunoglobulin (Erig) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Equine Rabies Immunoglobulin (Erig) Sales by Country (2020-2025) & (K MT)
Table 50. South America Equine Rabies Immunoglobulin (Erig) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Equine Rabies Immunoglobulin (Erig) Production (K MT) by Region(2020-2025)
Table 54. Global Equine Rabies Immunoglobulin (Erig) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Equine Rabies Immunoglobulin (Erig) Revenue Market Share by Region (2020-2025)
Table 56. Global Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Serum China Basic Information
Table 62. Serum China Equine Rabies Immunoglobulin (Erig) Product Overview
Table 63. Serum China Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Serum China Business Overview
Table 65. Serum China SWOT Analysis
Table 66. Serum China Recent Developments
Table 67. Lanzhou Institute of Biological Products Basic Information
Table 68. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
Table 69. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Lanzhou Institute of Biological Products Business Overview
Table 71. Lanzhou Institute of Biological Products SWOT Analysis
Table 72. Lanzhou Institute of Biological Products Recent Developments
Table 73. Wuhan Institute of Biological Products Basic Information
Table 74. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
Table 75. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Wuhan Institute of Biological Products Business Overview
Table 77. Wuhan Institute of Biological Products SWOT Analysis
Table 78. Wuhan Institute of Biological Products Recent Developments
Table 79. Premium Serums Basic Information
Table 80. Premium Serums Equine Rabies Immunoglobulin (Erig) Product Overview
Table 81. Premium Serums Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Premium Serums Business Overview
Table 83. Premium Serums Recent Developments
Table 84. Haffkine Bio-Pharmaceutical Basic Information
Table 85. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Product Overview
Table 86. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Haffkine Bio-Pharmaceutical Business Overview
Table 88. Haffkine Bio-Pharmaceutical Recent Developments
Table 89. Bharat Serums Basic Information
Table 90. Bharat Serums Equine Rabies Immunoglobulin (Erig) Product Overview
Table 91. Bharat Serums Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Bharat Serums Business Overview
Table 93. Bharat Serums Recent Developments
Table 94. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Equine Rabies Immunoglobulin (Erig) Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Equine Rabies Immunoglobulin (Erig) Market Size Comparison by Region (M USD)
Table 5. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Equine Rabies Immunoglobulin (Erig) Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Equine Rabies Immunoglobulin (Erig) Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (Erig) as of 2024)
Table 10. Global Market Equine Rabies Immunoglobulin (Erig) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Equine Rabies Immunoglobulin (Erig) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Equine Rabies Immunoglobulin (Erig) Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Equine Rabies Immunoglobulin (Erig) Sales by Type (K MT)
Table 26. Global Equine Rabies Immunoglobulin (Erig) Market Size by Type (M USD)
Table 27. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) by Type (2020-2025)
Table 28. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Type (2020-2025)
Table 29. Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) by Type (2020-2025)
Table 30. Global Equine Rabies Immunoglobulin (Erig) Market Size Share by Type (2020-2025)
Table 31. Global Equine Rabies Immunoglobulin (Erig) Price (USD/KG) by Type (2020-2025)
Table 32. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) by Application
Table 33. Global Equine Rabies Immunoglobulin (Erig) Market Size by Application
Table 34. Global Equine Rabies Immunoglobulin (Erig) Sales by Application (2020-2025) & (K MT)
Table 35. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Application (2020-2025)
Table 36. Global Equine Rabies Immunoglobulin (Erig) Market Size by Application (2020-2025) & (M USD)
Table 37. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application (2020-2025)
Table 38. Global Equine Rabies Immunoglobulin (Erig) Sales Growth Rate by Application (2020-2025)
Table 39. Global Equine Rabies Immunoglobulin (Erig) Sales by Region (2020-2025) & (K MT)
Table 40. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region (2020-2025)
Table 41. Global Equine Rabies Immunoglobulin (Erig) Market Size by Region (2020-2025) & (M USD)
Table 42. Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region (2020-2025)
Table 43. North America Equine Rabies Immunoglobulin (Erig) Sales by Country (2020-2025) & (K MT)
Table 44. North America Equine Rabies Immunoglobulin (Erig) Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Equine Rabies Immunoglobulin (Erig) Sales by Country (2020-2025) & (K MT)
Table 46. Europe Equine Rabies Immunoglobulin (Erig) Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size by Region (2020-2025) & (M USD)
Table 49. South America Equine Rabies Immunoglobulin (Erig) Sales by Country (2020-2025) & (K MT)
Table 50. South America Equine Rabies Immunoglobulin (Erig) Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size by Region (2020-2025) & (M USD)
Table 53. Global Equine Rabies Immunoglobulin (Erig) Production (K MT) by Region(2020-2025)
Table 54. Global Equine Rabies Immunoglobulin (Erig) Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Equine Rabies Immunoglobulin (Erig) Revenue Market Share by Region (2020-2025)
Table 56. Global Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Equine Rabies Immunoglobulin (Erig) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Serum China Basic Information
Table 62. Serum China Equine Rabies Immunoglobulin (Erig) Product Overview
Table 63. Serum China Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Serum China Business Overview
Table 65. Serum China SWOT Analysis
Table 66. Serum China Recent Developments
Table 67. Lanzhou Institute of Biological Products Basic Information
Table 68. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
Table 69. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Lanzhou Institute of Biological Products Business Overview
Table 71. Lanzhou Institute of Biological Products SWOT Analysis
Table 72. Lanzhou Institute of Biological Products Recent Developments
Table 73. Wuhan Institute of Biological Products Basic Information
Table 74. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Product Overview
Table 75. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Wuhan Institute of Biological Products Business Overview
Table 77. Wuhan Institute of Biological Products SWOT Analysis
Table 78. Wuhan Institute of Biological Products Recent Developments
Table 79. Premium Serums Basic Information
Table 80. Premium Serums Equine Rabies Immunoglobulin (Erig) Product Overview
Table 81. Premium Serums Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Premium Serums Business Overview
Table 83. Premium Serums Recent Developments
Table 84. Haffkine Bio-Pharmaceutical Basic Information
Table 85. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Product Overview
Table 86. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Haffkine Bio-Pharmaceutical Business Overview
Table 88. Haffkine Bio-Pharmaceutical Recent Developments
Table 89. Bharat Serums Basic Information
Table 90. Bharat Serums Equine Rabies Immunoglobulin (Erig) Product Overview
Table 91. Bharat Serums Equine Rabies Immunoglobulin (Erig) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Bharat Serums Business Overview
Table 93. Bharat Serums Recent Developments
Table 94. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Region (2026-2033) & (K MT)
Table 95. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Region (2026-2033) & (M USD)
Table 96. North America Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (K MT)
Table 97. North America Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 98. Europe Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (K MT)
Table 99. Europe Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 100. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales Forecast by Region (2026-2033) & (K MT)
Table 101. Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Region (2026-2033) & (M USD)
Table 102. South America Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (K MT)
Table 103. South America Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales Forecast by Country (2026-2033) & (Units)
Table 105. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Country (2026-2033) & (M USD)
Table 106. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Type (2026-2033) & (K MT)
Table 107. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Type (2026-2033) & (M USD)
Table 108. Global Equine Rabies Immunoglobulin (Erig) Price Forecast by Type (2026-2033) & (USD/KG)
Table 109. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) Forecast by Application (2026-2033)
Table 110. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Equine Rabies Immunoglobulin (Erig)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD), 2024-2033
Figure 5. Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) (2020-2033)
Figure 6. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Rabies Immunoglobulin (Erig) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Equine Rabies Immunoglobulin (Erig) Product Life Cycle
Figure 13. Equine Rabies Immunoglobulin (Erig) Sales Share by Manufacturers in 2024
Figure 14. Global Equine Rabies Immunoglobulin (Erig) Revenue Share by Manufacturers in 2024
Figure 15. Equine Rabies Immunoglobulin (Erig) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Equine Rabies Immunoglobulin (Erig) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Equine Rabies Immunoglobulin (Erig) Revenue in 2024
Figure 18. Industry Chain Map of Equine Rabies Immunoglobulin (Erig)
Figure 19. Global Equine Rabies Immunoglobulin (Erig) Market PEST Analysis
Figure 20. Global Equine Rabies Immunoglobulin (Erig) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Equine Rabies Immunoglobulin (Erig) Market Share by Type
Figure 27. Sales Market Share of Equine Rabies Immunoglobulin (Erig) by Type (2020-2025)
Figure 28. Sales Market Share of Equine Rabies Immunoglobulin (Erig) by Type in 2024
Figure 29. Market Size Share of Equine Rabies Immunoglobulin (Erig) by Type (2020-2025)
Figure 30. Market Size Share of Equine Rabies Immunoglobulin (Erig) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application
Figure 33. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Application (2020-2025)
Figure 34. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Application in 2024
Figure 35. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application (2020-2025)
Figure 36. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application in 2024
Figure 37. Global Equine Rabies Immunoglobulin (Erig) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region (2020-2025)
Figure 39. Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region (2020-2025)
Figure 40. North America Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Equine Rabies Immunoglobulin (Erig) Sales Market Share by Country in 2024
Figure 43. North America Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Country in 2024
Figure 45. U.S. Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Equine Rabies Immunoglobulin (Erig) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Equine Rabies Immunoglobulin (Erig) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Equine Rabies Immunoglobulin (Erig) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Equine Rabies Immunoglobulin (Erig) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Equine Rabies Immunoglobulin (Erig) Sales Market Share by Country in 2024
Figure 53. Europe Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Country in 2024
Figure 55. Germany Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region in 2024
Figure 68. China Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (K MT)
Figure 79. South America Equine Rabies Immunoglobulin (Erig) Sales Market Share by Country in 2024
Figure 80. South America Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (M USD)
Figure 81. South America Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Country in 2024
Figure 82. Brazil Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Equine Rabies Immunoglobulin (Erig) Production Market Share by Region (2020-2025)
Figure 103. North America Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Equine Rabies Immunoglobulin (Erig) Market Share Forecast by Type (2026-2033)
Figure 111. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Application (2026-2033)
Figure 112. Global Equine Rabies Immunoglobulin (Erig) Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Equine Rabies Immunoglobulin (Erig)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD), 2024-2033
Figure 5. Global Equine Rabies Immunoglobulin (Erig) Market Size (M USD) (2020-2033)
Figure 6. Global Equine Rabies Immunoglobulin (Erig) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Equine Rabies Immunoglobulin (Erig) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Equine Rabies Immunoglobulin (Erig) Product Life Cycle
Figure 13. Equine Rabies Immunoglobulin (Erig) Sales Share by Manufacturers in 2024
Figure 14. Global Equine Rabies Immunoglobulin (Erig) Revenue Share by Manufacturers in 2024
Figure 15. Equine Rabies Immunoglobulin (Erig) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Equine Rabies Immunoglobulin (Erig) Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Equine Rabies Immunoglobulin (Erig) Revenue in 2024
Figure 18. Industry Chain Map of Equine Rabies Immunoglobulin (Erig)
Figure 19. Global Equine Rabies Immunoglobulin (Erig) Market PEST Analysis
Figure 20. Global Equine Rabies Immunoglobulin (Erig) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Equine Rabies Immunoglobulin (Erig) Market Share by Type
Figure 27. Sales Market Share of Equine Rabies Immunoglobulin (Erig) by Type (2020-2025)
Figure 28. Sales Market Share of Equine Rabies Immunoglobulin (Erig) by Type in 2024
Figure 29. Market Size Share of Equine Rabies Immunoglobulin (Erig) by Type (2020-2025)
Figure 30. Market Size Share of Equine Rabies Immunoglobulin (Erig) by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application
Figure 33. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Application (2020-2025)
Figure 34. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Application in 2024
Figure 35. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application (2020-2025)
Figure 36. Global Equine Rabies Immunoglobulin (Erig) Market Share by Application in 2024
Figure 37. Global Equine Rabies Immunoglobulin (Erig) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region (2020-2025)
Figure 39. Global Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region (2020-2025)
Figure 40. North America Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Equine Rabies Immunoglobulin (Erig) Sales Market Share by Country in 2024
Figure 43. North America Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Country in 2024
Figure 45. U.S. Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Equine Rabies Immunoglobulin (Erig) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Equine Rabies Immunoglobulin (Erig) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Equine Rabies Immunoglobulin (Erig) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Equine Rabies Immunoglobulin (Erig) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Equine Rabies Immunoglobulin (Erig) Sales Market Share by Country in 2024
Figure 53. Europe Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Country in 2024
Figure 55. Germany Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region in 2024
Figure 68. China Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (K MT)
Figure 79. South America Equine Rabies Immunoglobulin (Erig) Sales Market Share by Country in 2024
Figure 80. South America Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (M USD)
Figure 81. South America Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Country in 2024
Figure 82. Brazil Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Equine Rabies Immunoglobulin (Erig) Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Equine Rabies Immunoglobulin (Erig) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Equine Rabies Immunoglobulin (Erig) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Equine Rabies Immunoglobulin (Erig) Production Market Share by Region (2020-2025)
Figure 103. North America Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 106. China Equine Rabies Immunoglobulin (Erig) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Equine Rabies Immunoglobulin (Erig) Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Equine Rabies Immunoglobulin (Erig) Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Equine Rabies Immunoglobulin (Erig) Market Share Forecast by Type (2026-2033)
Figure 111. Global Equine Rabies Immunoglobulin (Erig) Sales Forecast by Application (2026-2033)
Figure 112. Global Equine Rabies Immunoglobulin (Erig) Market Share Forecast by Application (2026-2033)
